BFRI
NASDAQ
$1.05
Biofrontera Inc (BFRI)
Biofrontera Inc., a biopharmaceutical company, develops and supplies dermatological products for the treatment of skin conditions in the United States. The company is headquartered in Woburn, Massachusetts.
Sector:
Healthcare
Target: $5.88 (+460.00%)
Market Cap
$13M
Free Cash Flow Yield
-72.03%
Beta (5Y)
1.01
Price Chart
Valuation
Market Cap$13M
Forward P/E13.64
P/S0.32
P/B2.24
Profitability
Total Revenue (TTM)$43M
Gross Profit (TTM)$33M
EBITDA-$11M
Profit Margin-47.1%
Operating Margin-42.8%
EPS-$1.01
Financial Health
Free Cash Flow Yield-72.03%
Growth & Risk
Beta (5Y)1.01
Sharpe Ratio0.61